Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Kumar

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Oncology (Williston Park, N.Y.)|October 19, 2016
The Emerging Role of Checkpoint Inhibitor Therapy in Hodgkin LymphomaAnita Kumar
Current Oncology Reports|June 6, 2015
Novel agents in mantle cell lymphomaAnita Kumar
Haematologica|October 19, 2023
MYC overexpression: adding another piece to the puzzle of high-risk mantle cell lymphomaAnita Kumar
Culture, Medicine and Psychiatry|October 18, 2013
The play is now reality: affective turns, narrative struggles, and theorizing emotion as practical experienceAnita Kumar
Hematology. American Society of Hematology. Education Program|December 9, 2022
What is the role of up-front autologous stem cell transplantation in mantle cell lymphoma?Anita Kumar
American Journal of Psychotherapy|February 14, 2025
The Private Loss of Dr. MAnita Kumar Chang
Current Treatment Options in Oncology|February 27, 2014
Role of CD30 targeting in malignant lymphomaAnita Kumar, Anas Younes
Expert Review of Hematology|February 7, 2023
Personalized approaches for treatment-naïve mantle cell lymphomaDavid Qualls, Anita Kumar
Hematology/Oncology Clinics of North America|June 24, 2019
Mantle Cell Lymphoma: Current and Emerging Treatment Strategies and Unanswered QuestionsBenjamin Diamond, Anita Kumar
Blood Reviews|June 21, 2024
Dismantling relapsed/refractory mantle cell lymphomaChristine E Ryan, Anita Kumar
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Oncology (Williston Park, N.Y.)|October 19, 2016
The Emerging Role of Checkpoint Inhibitor Therapy in Hodgkin LymphomaAnita Kumar
Current Oncology Reports|June 6, 2015
Novel agents in mantle cell lymphomaAnita Kumar
Haematologica|October 19, 2023
MYC overexpression: adding another piece to the puzzle of high-risk mantle cell lymphomaAnita Kumar
Culture, Medicine and Psychiatry|October 18, 2013
The play is now reality: affective turns, narrative struggles, and theorizing emotion as practical experienceAnita Kumar
Hematology. American Society of Hematology. Education Program|December 9, 2022
What is the role of up-front autologous stem cell transplantation in mantle cell lymphoma?Anita Kumar
American Journal of Psychotherapy|February 14, 2025
The Private Loss of Dr. MAnita Kumar Chang
Current Treatment Options in Oncology|February 27, 2014
Role of CD30 targeting in malignant lymphomaAnita Kumar, Anas Younes
Expert Review of Hematology|February 7, 2023
Personalized approaches for treatment-naïve mantle cell lymphomaDavid Qualls, Anita Kumar
Hematology/Oncology Clinics of North America|June 24, 2019
Mantle Cell Lymphoma: Current and Emerging Treatment Strategies and Unanswered QuestionsBenjamin Diamond, Anita Kumar
Blood Reviews|June 21, 2024
Dismantling relapsed/refractory mantle cell lymphomaChristine E Ryan, Anita Kumar
Pageof 16